Part II--drug shortages: Big pharma's new business model.
American Enterprise Institute, USA. scott.gottlieb@aei.org
Scott
S
Gottleib
D035843:Biomedical Research / Q000191:economics*; D017277:Drug Approval / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D006801:Humans